Xeris Biopharma to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 10, 2021
November 02 2021 - 7:30AM
Business Wire
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a
biopharmaceutical company developing and commercializing unique
therapies for patient populations in endocrinology, neurology, and
gastroenterology, today announced that the Company will release its
third quarter 2021 financial results before the open of the U.S.
financial markets on Wednesday, November 10, 2021. Management will
host a conference call and webcast at 8:30 a.m. Eastern Time that
day to discuss the Company’s financial and operational results.
To pre-register for the conference call please use this link:
https://www.incommglobalevents.com/registration/q4inc/9056/xeris-biopharma-third-quarter-2021-financial-results/
After registering, a confirmation email will be sent, including
dial-in details and a unique code for entry. The Company recommends
registering a minimum of ten minutes prior to the start of the
call. Following the conference call, a replay will be available
until Wednesday, November 24, 2021, at US: 1 929 458 6194, US Toll
Free: 1 866 813 9403, UK: 0204 525 0658, Canada: 1 226 828 7578, or
all other locations: +44 204 525 0658 Access Code: 508975
About Xeris Biopharma Holdings, Inc.
Xeris (Nasdaq: XERS), is a biopharmaceutical company developing
and commercializing unique therapies for patient populations in
endocrinology, neurology, and gastroenterology. Xeris has two
commercially available products, Gvoke®, a ready-to-use liquid
glucagon for the treatment of severe hypoglycemia and Keveyis®, the
first and only FDA-approved therapy for primary periodic paralysis.
Xeris also has a robust pipeline of development programs to extend
the current marketed products into important new indications and
uses and bring new products forward using its proprietary
formulation technology platforms, XeriSol™ and XeriJect™,
supporting long-term product development and commercial
success.
Xeris Biopharma Holdings is headquartered in Chicago, IL. For
more information, visit www.xerispharma.com, or follow us on
Twitter, LinkedIn or Instagram.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211102005312/en/
Investor Contact Allison Wey Senior Vice President,
Investor Relations and Corporate Communications
awey@xerispharma.com 312-736-1237
Xeris Biopharma (NASDAQ:XERS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Xeris Biopharma (NASDAQ:XERS)
Historical Stock Chart
From Oct 2023 to Oct 2024